- Home
- ACLX vs AMED Comparison
ACLX vs AMED Comparison
Compare ACLX & AMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACLX
- AMED
- Stock Information
- Founded
- ACLX 2015
- AMED 1982
- Country
- ACLX United States
- AMED United States
- Employees
- ACLX N/A
- AMED N/A
- Industry
- ACLX Biotechnology: Pharmaceutical Preparations
- AMED Medical/Nursing Services
- Sector
- ACLX Health Care
- AMED Health Care
- Exchange
- ACLX Nasdaq
- AMED Nasdaq
- Market Cap
- ACLX 3.5B
- AMED 3.2B
- IPO Year
- ACLX 2022
- AMED N/A
- Fundamental
- Price
- ACLX $67.16
- AMED $96.10
- Analyst Decision
- ACLX Strong Buy
- AMED Hold
- Analyst Count
- ACLX 14
- AMED 5
- Target Price
- ACLX $111.42
- AMED $100.80
- AVG Volume (30 Days)
- ACLX 567.9K
- AMED 483.4K
- Earning Date
- ACLX 08-07-2025
- AMED 07-23-2025
- Dividend Yield
- ACLX N/A
- AMED N/A
- EPS Growth
- ACLX N/A
- AMED N/A
- EPS
- ACLX N/A
- AMED 2.72
- Revenue
- ACLX $76,809,000.00
- AMED $2,371,691,000.00
- Revenue This Year
- ACLX N/A
- AMED $6.29
- Revenue Next Year
- ACLX $112.68
- AMED $5.25
- P/E Ratio
- ACLX N/A
- AMED $35.39
- Revenue Growth
- ACLX N/A
- AMED 5.34
- 52 Week Low
- ACLX $47.86
- AMED $82.15
- 52 Week High
- ACLX $107.37
- AMED $98.95
- Technical
- Relative Strength Index (RSI)
- ACLX 59.84
- AMED 48.12
- Support Level
- ACLX $63.13
- AMED $95.55
- Resistance Level
- ACLX $67.83
- AMED $98.43
- Average True Range (ATR)
- ACLX 2.52
- AMED 0.66
- MACD
- ACLX 0.14
- AMED -0.24
- Stochastic Oscillator
- ACLX 90.30
- AMED 20.75
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.
About AMED Amedisys Inc
Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, and high acuity care segment. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States; the Hospice segment operates many centers designed to provide comfort and support for terminally ill patients; and the High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.